Multiple Securities Fraud Class Actions Filed Against Elevance Health, Zynex Investors

Two major securities class action lawsuits have been filed against Elevance Health, Inc. and Zynex, Inc., alleging violations of federal securities laws. The Elevance lawsuit claims the company and its executives misrepresented the impact of Medicaid redeterminations on patient acuity and utilization, leading to understated financial risks and a stock decline after the truth was revealed. Meanwhile, multiple law firms have filed suits against Zynex, accusing the company of shipping excessive medical products to inflate revenues, which prompted insurer scrutiny and regulatory risks, contributing to a stock drop. Investors who purchased shares of Elevance or Zynex during the respective class periods are encouraged to join the lawsuits and may be eligible for compensation. Deadlines for lead plaintiff motions are approaching—July 11, 2025, for Elevance and May 19, 2025, for Zynex. Several prominent law firms are actively seeking clients for these cases, highlighting their experience and successes in securities litigation.